Roche wins EU nod for anaemia drug
Roche Holding AG, the biggest maker of cancer medicines, won European approval for a new use of its blood disorder medicine NeoRecormon in cancer patients. The European Commission granted marketing
Roche Holding AG, the biggest maker of cancer medicines, won European approval for a new use of its blood disorder medicine NeoRecormon in cancer patients. The European Commission granted marketing